OUR PRODUCTS

MOBILE APPS

GENERAL INFO

TRDA

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Entrada Therapeutics (TRDA) Earnings Date & Reports

Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

TRDA is expected to report earnings to fall 4.81% to -99 cents per share on November 11

Entrada Therapeutics TRDA Stock Earnings Reports

Q3'25

Est.

$-0.99

Q2'25

Missed

by $0.22

Q1'25

Beat

by $0.31

Q4'24

Beat

by $0.70

Q3'24

Beat

by $0.38

The last earnings report on August 06 showed earnings per share of -103 cents, missing the estimate of -81 cents. With 113.25K shares outstanding, the current market capitalization sits at 190.19M.

View a ticker or compare two or three

Compare

TRDA

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For TRDA
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TRDA showed earnings on August 06, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

One Design Center Place

Phone

+1 857 520-9158

Employees

159

Web

https://www.entradatx.com